Product Information
HYDROCODONE-IBUPROFEN 7.5-200 is a generic product labeled by Aurolife Pharma LLC, priced at $0.4870 per EA under NDC 13107000401. Its NADAC has been published 485 times since Jun 21, 2017.
FDA first approved this application on Jun 2, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5; 200 mg/1; mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107000401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCODONE BITARTRATE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA204575FDA Approved
6/2/2016
TE Code
AB
On Market Since
6/2/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-IBUPROFEN 7.5-200 has been published 485 times since Jun 21, 2017, and over the history we have for it it has risen 73.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4870 per EA |
|---|---|
| All-time high | $0.4891 (May 13, 2026) |
| All-time low | $0.1692 (Jun 22, 2022) |
| 52-week high | $0.4891 |
| 52-week low | $0.4767 |
| Median price | $0.2758 |
| Average price | $0.3319 |
| Largest weekly change | +26.5% (Apr 19, 2023) |
| Weeks tracked | 485 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurolife Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate and Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-IBUPROFEN 7.5-200?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-IBUPROFEN 7.5-200, manufactured by Aurolife Pharma LLC, is $0.4870 per EA (NDC 13107000401), effective Sep 30, 2026.
How has the price of HYDROCODONE-IBUPROFEN 7.5-200 changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-IBUPROFEN 7.5-200 has risen 73.6%. It has been tracked across 485 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-IBUPROFEN 7.5-200?
Since Jun 21, 2017, the NADAC for HYDROCODONE-IBUPROFEN 7.5-200 has ranged from a low of $0.1692 (Jun 22, 2022) to a high of $0.4891 (May 13, 2026), with a median of $0.2758 per EA.
Are there cheaper alternatives to HYDROCODONE-IBUPROFEN 7.5-200?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-IBUPROFEN 7.5-200 in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROCODONE-IBUPROFEN 7.5-200?
HYDROCODONE-IBUPROFEN 7.5-200 (NDC 13107000401) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.